A Study of Centanafadine in Pediatrics with Attention Deficit Hyperactivity Disorder
- Ages 4-5
- Diagnosis of or symptoms consistent with ADHD
- Able to swallow a capsule
- Has not benefited from therapeutic intervention, or symptoms are severe enough to warrant medication intervention
- If you have history of medical issues such as seizures, blood disorders, or other major health conditions you may not qualify for this trial
- Open-label study to follow
- Method of Administration: Oral / Capsule
- Length/Duration: 7 Weekly Visits
- Location: 721 North Magnolia Avenue, Orlando FL 32803
- Compensation: $125 / visit
- Participants may:
- See a doctor or medical staff at no cost
- Have access to trial medications
- Receive compensation for time and travel